Ding et al., 2019 - Google Patents
Antibody purification process development and manufacturingDing et al., 2019
View HTML- Document ID
- 15183043272570552548
- Author
- Ding Y
- Kumar H
- Marino M
- Publication year
External Links
Snippet
A biotech company's journey to develop a protein-based therapeutic drug from discovery, process development, manufacturing, and clinical trials to commercialization is long and complex. Multiple activities are involved, and many challenges are encountered when …
- 238000004519 manufacturing process 0 title abstract description 33
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3847—Multimodal interactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Recovery and purification process development for monoclonal antibody production | |
Nestola et al. | Improved virus purification processes for vaccines and gene therapy | |
Singh et al. | Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives | |
Kelley | Downstream processing of monoclonal antibodies: current practices and future opportunities | |
Shukla et al. | Viral clearance for biopharmaceutical downstream processes | |
Marichal‐Gallardo et al. | State‐of‐the‐art in downstream processing of monoclonal antibodies: Process trends in design and validation | |
Rathore et al. | Recent developments in membrane-based separations in biotechnology processes | |
Shukla et al. | Downstream processing of monoclonal antibodies—application of platform approaches | |
Marichal-Gallardo et al. | Single-use capture purification of adeno-associated viral gene transfer vectors by membrane-based steric exclusion chromatography | |
KR20190122272A (en) | Methods of purifying recombinant adamts13 and other proteins and compositions thereof | |
KR20220034249A (en) | Process control systems and methods for use with filters and filtration processes | |
JP2022058979A (en) | Virus filtration | |
Shamashkin et al. | A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode | |
CN110066314A (en) | A kind of efficient affinity purification technique for improving polymer separation resolution ratio | |
Ding et al. | Antibody purification process development and manufacturing | |
Hughson et al. | Development of a 3‐step straight‐through purification strategy combining membrane adsorbers and resins | |
Loewe et al. | Opportunities to debottleneck the downstream processing of the oncolytic measles virus | |
Cibelli et al. | Advances in purification of SARS-CoV-2 spike ectodomain protein using high-throughput screening and non-affinity methods | |
Mehta et al. | Next-generation process design for monoclonal antibody purification | |
Faber et al. | Salt tolerant interaction chromatography for large-scale polishing with convective media | |
JP7445332B2 (en) | Optimized method for bevacizumab purification | |
Ferreira et al. | Chromatography: A Two-Column Process To Purify Antibodies Without Protein A | |
Namila | The effects of solution condition on virus filtration performance | |
Ding et al. | Points to Consider for Continuous Downstream Bioprocessing | |
Brorson | Advances in viral clearance |